Market Exclusive

Analyst Activity – Royal Bank of Canada Initiates Coverage On NASDAQ:ARNA – Arena Pharmaceuticals (NASDAQ:ARNA) With a Outperform

Analyst Ratings For NASDAQ:ARNA – Arena Pharmaceuticals (NASDAQ:ARNA)

Today, Royal Bank of Canada initiated coverage on NASDAQ:ARNA – Arena Pharmaceuticals (NASDAQ:ARNA) with a Outperform with a price target of $65.00.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:ARNA – Arena Pharmaceuticals (NASDAQ:ARNA)
NASDAQ:ARNA – Arena Pharmaceuticals (NASDAQ:ARNA) has insider ownership of 1.88% and institutional ownership of 77.52%.

Recent Trading Activity for NASDAQ:ARNA – Arena Pharmaceuticals (NASDAQ:ARNA)
Shares of NASDAQ:ARNA – Arena Pharmaceuticals closed the previous trading session at 45.20 up +0.96 2.17% with 44.54999923706055 shares trading hands.

Exit mobile version